MetaCap

Mineralys Therapeutics Statistics

NASDAQ: MLYSHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.66-0.50 (-3.53%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Mineralys Therapeutics by the numbers

Mineralys Therapeutics has a market capitalization of $1.21 billion based on 88.56M shares outstanding. With trailing EPS of $-4.30, Mineralys Therapeutics is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 35.3% below its 50-day average and 46.9% below its 200-day average.

Average daily trading volume is 1.55M shares, or about $21.2 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

MLYS valuation vs. peer median

MLYS compared with the median of 8 peer companies
MetricMLYSPeer medianDifference
Market cap$1.21B$1.23B-2%
Avg. volume1.55M1.82M-15%

Peer median across 8 companies: AMPH, GHRS, OCUL, GENB, SLN, MNKD, OPK, LBRX.

Valuation

Price and trading

Previous close
14.16
Open
13.81
Day range
13.57 – 14.79
52-week range
13.57 – 44.13
52-week change
-67.38%
Beta
—
Volume
1.35M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.21B
Forward Pe
-5.63
Eps
-4.30
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
44.13
Week52 Low
13.57
Avg Volume
1.55M
Shares Outstanding
88.56M
Ma50
21.12
Ma200
25.75
Earnings Date
Nov 4, 2026
Pct From52w High
-69.05%
Pct From52w Low
0.66%

Related